- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
Showing 1–12 of 84 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
|---|---|---|---|---|---|---|---|---|---|---|
CD33 |
Antibody-drug conjugate (ADC) |
Mylotarg® |
1 mg/mL |
– |
0,1 mg |
-80°C |
2024.08 |
1.161,00Â € |
||
CD33 |
Antibody-drug conjugate (ADC) |
Mylotarg® |
1 mg/mL |
– |
0,1 mg |
-80°C |
2025.03 |
1.161,00Â € |
||
CD20 |
Monoclonal Antibody |
Zevalin® |
1.6 mg/mL |
– |
0.1 mg |
tba |
tba |
2.317,00Â € |
||
CD22 |
Antibody-drug conjugate (ADC) |
Besponsa® |
0,25 mg/mL |
– |
0,02 mg |
tba |
tba |
1.502,00Â € |
||
CD19 |
Antibody-drug conjugate (ADC) |
Zynlonta® |
5 mg/mL |
– |
0,5 mg |
-80 °C |
04/2026 |
1.856,00Â € |
||
FRÉ‘ |
Antibody-drug conjugate (ADC) |
Elahere® |
5 mg/mL |
– |
2 mg |
-80 °C |
2029.09 |
599,00Â € |
||
CCR4 |
Monoclonal Antibody |
Poteligeo® |
4 mg/mL |
– |
0,5 mg |
-80 °C |
2023.09 |
358,00Â € |
||
CD20 , CD3 |
Bispecific Antibody |
Lunsumio® |
1 mg/mL |
– |
0.05 mg |
tba |
tba |
316,00Â € |
||
CD20 |
Monoclonal Antibody |
Gazyvaro® |
25 mg/mL |
– |
6 mg |
-80°C |
2019.06 |
250,00Â € |
||
CD20 |
Monoclonal Antibody |
Gazyvaro® |
25 mg/mL |
– |
6 mg |
-80°C |
2019.08 |
250,00Â € |
||
Tubulin |
Nanoparticle |
Abraxane® |
5 mg/mL |
– |
5 mg |
-80°C |
2026.02 |
355,00Â € |
||
EGFR |
Monoclonal Antibody |
Vectibix® |
20 mg/mL |
– |
4 mg |
-80 °C |
2025.07 |
355,00Â € |
||
HER2 |
Monoclonal Antibody |
Perjeta® |
30 mg/mL |
– |
6 mg |
tba |
tba |
396,00Â € |
||
HER2 |
Monoclonal Antibody |
Phesgo® |
60 mg/mL |
– |
12 mg |
tba |
tba |
717,00Â € |
||
CD79b |
Antibody-drug conjugate (ADC) |
Polivy® |
20 mg/mL |
– |
1 mg |
-80 °C |
2024.06 |
552,00Â € |
||
VEGFR2 |
Monoclonal Antibody |
Cyramza® |
10 mg/mL |
– |
2 mg |
-80°C |
2018.03 |
209,00Â € |
||
VEGFR2 |
Monoclonal Antibody |
Cyramza® |
10 mg/mL |
– |
2 mg |
-80°C |
2018.06 |
209,00Â € |
||
VEGFR2 |
Monoclonal Antibody |
Cyramza® |
10 mg/mL |
– |
2 mg |
-80°C |
2018.08 |
209,00Â € |
||
VEGFR2 |
Monoclonal Antibody |
Cyramza® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.01 |
209,00Â € |
||
VEGFR2 |
Monoclonal Antibody |
Cyramza® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.12 |
209,00Â € |
||
VEGFR2 |
Monoclonal Antibody |
Cyramza® |
10 mg/mL |
– |
2 mg |
-80°C |
2020.06 |
209,00Â € |
||
CD20 |
Biosimilar , Monoclonal Antibody |
Truxima® |
10 mg/mL |
– |
2 mg |
tba |
tba |
234,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2018.05 |
145,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2018.09 |
145,00Â € |
||
CD20 |
Biosimilar , Monoclonal Antibody |
Ruxience® |
10 mg/mL |
– |
2 mg |
-80 °C |
2025.12 |
202,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2018.12 |
145,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.02 |
145,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.02 |
145,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.08 |
145,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.12 |
145,00Â € |
